JHVEPhoto/iStock Editorial via Getty Images
Medical device maker Becton Dickinson & Co. (NYSE:BDX) rose 2.4% in premarket trading amid reports that the company is evaluating separating its life sciences segment, which way be valued at about $30 billion.
The company is looking at separating its